SECURITIES
AND EXCHANGE COMMISSION


Washington,
D.C. 20549





FORM
10-K





(Mark
One)





[ X ]
ANNUAL REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934





For the
fiscal year ended December 31, 2008





OR





[    ]
TRANSITION REPORT UNDER SECTION
13 OF 15(d) OF THE EXCHANGE ACT OF 1934





From the
transition period from ___________ to ____________.





Commission
File Number 333-142979





TRIPLE A MEDICAL,
INC.


(Exact
name of small business issuer as specified in its charter)





Nevada
              20-4846807(State
      or other jurisdiction of incorporation or organization)
              (IRS
      Employer Identification No.)




604 Creekview, Ovilla, Texas
75154


(Address
of principal executive offices)





(800)
843-8179


(Issuer's
telephone number)





N/A


(Former name, former address and former
fiscal year, if changed since last report)





Indicate
by a check mark if the registrant is a well-known seasoned issuer, as defined by
Rule 405 of the Securities Act.  Yes
[   ]  No [X]





Indicate
by a check mark if the registrant is not required to file reports pursuant to
Section 13 or Section 15(d) of the Securities Act.  Yes
[   ]  No [X]





Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of
Regulation S-K (s229.405 of this chapter) is not contained herein, and will not
be contained, to the best of registrant’s knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. [   ]




Indicate
by check mark whether the registrant (1) filed all reports required to be filed
by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days:.
 Yes [ X ]   No [   ].




Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer or a smaller reporting company. See
definitions of large accelerated filer, accelerated filer and smaller reporting
company in Rule 12b-2 of the Exchange Act. (Check one):




Large
      accelerated filer [  ]
            
            Accelerated
      filer [  ]Non-accelerated
      filer  [  ] (do not check if a smaller reporting
    company)
            
            Amaller
      reporting company [X]





Indicate
by a check mark whether the company is a shell company (as defined by Rule 12b-2
of the Exchange Act:  Yes [   ]   No
[X].





As of
March 26, 2009, there were 14,050,500 shares of Common Stock of the issuer
outstanding.











TABLE
OF CONTENTS








PagePART
      IITEM
      1
              Description
      of Business
              2ITEM
      2
              Description
      of Property
              3ITEM
      3
              Legal
      Proceedings
              3ITEM
      4
              Submission
      of Matters to a Vote of Security Holders
              3PART
      IIITEM
      5
              Market
      for Registrant’s Common Equity And Related Stockholders
      Matters
              4ITEM
      6
              Selected
      Financial Data
              4ITEM
      7
              Management’s
      Discussion and Analysis of Financial Condition and Results of
      Operation
              4ITEM
      7A
              Quantitative
      and Qualitative Disclosures About Market Risk
              5ITEM
      8
              Financial
      Statements and Supplementary Data
              F-1
      to F-11ITEM
      9
              Changes
      in and Disagreements with Accountants on Accounting and Financial
      Disclosure
              6ITEM
      9A
              Controls
      and Procedures
              6ITEM
      9B
              Other
      Information
              7PART
      IIIITEM
      10
              Directors,
      Executive Officers and Corporate Governance
              8ITEM
      11
              Executive
      Compensation
              8ITEM
      12
              Security
      Ownership of Certain Beneficial Owners and Management and Related
      Stockholder Matters
              8ITEM
      13
              Certain
      Relationships and Related Transactions, and Director
      Independence
              9ITEM
      14
              Principal
      Accounting Fees and Services
              9PART
      IVITEM
      15
              Exhibits
      and Financial Statement Schedules
              11EXHIBIT
      INDEXExhibit
      31.1
              Certification
      of Chief Executive Officer, pursuant to Rule 13a-14(a) of the Exchange
      Act, as enacted by Section 302 of the Sarbanes-Oxley Act of
      2002Exhibit
      31.2
              Certification
      of Chief Financial Officer, pursuant to Rule 13a-14(a) of the Exchange
      Act, as enacted by Section 302 of the Sarbanes-Oxley Act of
      2002Exhibit
      32.1
              Certification
      of Chief Executive Officer and Chief Financial Officer, pursuant to 18
      United States Code Section 1350, as enacted by Section 906 of the
      Sarbanes-Oxley Act of 2002SIGNATURES
              
              12


1








PART I.





ITEM
1.                      DESCRIPTION OF
BUSINESS





This
report contains forward looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended. The Company’s actual results could differ
materially from those set forth on the forward looking statements as a result of
the risks set forth in the Company’s filings with the Securities and Exchange
Commission, general economic conditions, and changes in the assumptions used in
making such forward looking statements.





General





The
company was founded to create electronic healthcare software
applications.  The initial development is an Electronic Health Record
(EHR), specifically designed to meet the needs of orthopedic physicians. For the
past 4 years, our President has worked directly with dozens of orthopedic
physicians in more than 40 states. He has reviewed orthopedic clinical research
and extensively surveyed reference materials. Based upon the research, Mr.
McCune created a database with a graphical interface to assist orthopedic
physicians with the documentation of the patient encounter.





The
Market





Phoenix
Ortho is participating in an $18 billion market for Electronic Health Records
(EHR). The Orthopedics market approaches $2 billion. There are more than 20,500
board certified orthopedists and 12,872 orthopedic group practices. Research
indicates that this market is less than 10% penetrated.  Recent
surveys indicate that 58% of medical practices are looking at purchasing an EHR
in the next 2 years. In 2005 the average orthopedic EHR sale was $171,000. (2001
AAOS Census, 2004 MGMA Survey) Recent growth rate in new sales has averaged
about 30%. We expected this growth rate will accelerate sharply over the next
two years.





Keys
to Success





Focus: We believe focus is the
essential ingredient to successful EHR development and deployment. Phoenix Ortho
is unique in our extensive experience and singular focus on orthopedics. By
focusing on one specialty, we can avoid the wholesale generalities that have
plagued EHR vendors and frustrated their orthopedic clients. Phoenix Ortho
understands the unique requirements of orthopedic physicians. Focus promotes the
creation of relevant content and specialty specific application functionality.
Content relevance is a significant factor in physician adoption.





In early
2007, we began marketing
a new orthopedic EHR. The new project was focused on resolving the key problems
that have historically posed barriers to adoption, successful implementation and
client satisfaction. These obstacles can be grouped together in four categories;
Product Functionality, Product Implementation, Product Support, Product
Acquisition Cost.





Product Functionality:The
software will establishnew standards for ease
of use, efficiency, stability and availability facilitating end user adoption.
The software is designed and scaled specifically for the pen tablet environment.
We believe the pen tablet is the device of choice for EHR end users. Our
development will utilize input tools such as sliders, combo boxes, role over
images and other custom designed tools to provide a truly keyboard free
interface. Other tablet input options such as “Pen and Ink” and “Voice to Text”
will be available as needed to capture representative content. The OD Client
will improve stability, performance and availability by utilizing .NET automatic
versioning and auto recovery from deadlock errors and memory leaks. Advanced
compilation and caching techniques substantially lower CPU utilization. The
ODClient (smart client) will support both disconnected and low bandwidth clients
supporting end user mobility and minimizing the frustration of “Systems
down”.








2





Product Implementation: We
have developed an orthopedic, client focused implementation methodology
we call the “AAA” implementation plan. This plan focuses on the three critical
aspects of implementation; Assessment, Adoption and Adaptation. All
implementations will begin with Assessment. During the assessment phase the
unique needs of the end users are identified. Each user is profiled to determine
their needs and potential road blocks to success. The physicians are identified
as Champions, Contenders or Challengers. An implementation strategy is designed
around these “Adoption Profiles”.  The Champions are the eager
adopters and should be the first users. The Contenders are frequently
indifferent but, usually agreeable adopters.  The Challengers
represent approximately 30% of the physicians who will resist implementation for
a variety of reasons. Sometimes they feel they are too technology challenged and
fearful, some are too busy and may fear loss of revenue by adoption, while
others are just resistant to anything new. When these objections are clearly
understood, “Adaptation” can take place and in most cases mitigate the
Challengers objection(s). Adaptation is the process of introducing (training)
the end users to the application “Best Practices”. It also takes into account
the “Profile” of the end user to create a “Best Practices” by provider (See
Challengers above).





Product Support:The ODClient
on the .NET framework makes it easier than ever to update and deploy new
applications. Thanks to intelligent, one touch updates and intelligent support
client PCs can be updated by copying the application to the target
directory.  Client PCs may be updated automatically with no
interruption or the may be updated on demand.







ITEM
2.                      DESCRIPTION
OF PROPERTY





Our
corporate facilities are located in a 1,200 sf office facility at 604 Creekview,
Ovilla, Texas 75154. The space is being leased on a month to month basis for
$5,000 per month.








ITEM
3.                      LEGAL
PROCEEDINGS





We are
not involved in any legal proceedings at this time.





ITEM
4.                      SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS





On
December 29, 2008, in the annual meeting of the shareholders, the security
holders elected the following directors of the corporation:





P. Morgan
McCune





3




PART
II





ITEM
      5.
            MARKET
      FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDERS
      MATTERS





The
common stock is currently quoted on the NASDAQ bulletin board under the symbol
“TAAA” and has been quoted since March of 2008.





The
following table sets forth the quarterly high and low prices paid (or if no
activity, the last sale price) for the Common Stock for 2008..





Fiscal
      2008
                    
                    High
                    
                    
                    LowFirst
      Quarter
                    
                    $
                    0.50
                    
                    
                    $
                    0.50Second
      Quarter
                    
                    $
                    0.50
                    
                    
                    $
                    0.50Third
      Quarter
                    
                    $
                    0.50
                    
                    
                    $
                    0.50Fourth
      Quarter
                    
                    $
                    0.50
                    
                    
                    $
                    0.50





Shareholders





As of
December 31, 2008, there were approximately 114 record holders of the Common
Stock. This number excludes any estimate by the Company of the number of
beneficial owners of shares held in street name, the accuracy of which cannot be
guaranteed.





Dividends


The
Company has not paid dividends on any class of common equity since formation and
the Company does not anticipate paying any dividends on its outstanding common
stock in the foreseeable future.





Warrants


The
Company has no warrants outstanding.








ITEM
6.                      SELECTED
FINANCIAL DATA





Not
required








ITEM
7.                      MANAGEMENT’S
DISCUSSION AND ANALYSIS OR PLAN OF OPERATION





Results
for the fiscal year ended December 31, 2008





At the
end of the first quarter of 2007, our software became operational and we started
marketing it by attending trade shows, print advertising and brochures and
personal contacts.  In August we had our first sale and installation
of the software which took us out of the development stage and into the
operating phase of our business. Our sales leads continue to be followed up on
as we receive them from our own efforts by attendance at trade shows and from
referrals from our industry cross marketing agreements.








4





REVENUE.  Revenue
for the year ended December 31, 2008 was $542,165 compared to $207,443 for 2007.
The increase is due to our marketing is making our software better
known.





EXPENSES.
Total expenses the twelve months ended December 31, 2008 was $1,325,205 compared
to $711,591 for the year of 2007. In  2008, the main components were
travel related to new installations of $271,179, employee leasing of $563,113,
contract services of $133,676 and software development costs of $26,500. We also
had bad debt expense of $95,799 in 2008 which resulted from a dispute over items
in one of our contracts. In 2007, the three main components of that expense were
software development costs, depreciation and amortization, and general and
administrative expenses. Software development costs are the amounts expended on
our software after it reached the point of being operational.





Depreciation
and amortization was $84,727 and $21,389 in 2008 and 2007
respectively.





In 2008,
we had selling, general and administrative expenses of $1,213,978 compared with
$434,765 in 2007. The significant increase is due to our marketing our software,
establishing our infrastructure for services clients and the marketing and
installation of double the sales we had in 2007, and the bad debt provision
mentioned above of $95,799.





OTHER
INCOME . We had interest income of $2,349 in 2008 and $5,526 in 2007. In 2008 we
had interest expense of $398 compared to $0 in 2007.





NET LOSS.
Net loss for the year ended December 31, 2008 was $781,089 compared with a loss
of $498,622 for the year of 2007. The losses in both years was due to our
company initial years of selling and marketing our software which started in
2007.





LIQUIDITY
AND CAPITAL RESOURCES. Our cash balance at December 31, 2008 was $47,954. We
raised a total of $258,750 in a public offering in 2008 and we believe it has
sustained us to the point we are now where our sales efforts are materializing
into sales and with the cash we have in the bank and the revenue we are seeing
from sales, we believe we will have enough liquidity to carry us to the point
where ales of our software provide enough cash flow to internally fund our
operations.





Employees





As of
December 31, 2008, the Company had six employees.








ITEM
7A.                    QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK





Not
applicable








5




ITEM
8.                      FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA





Incorporated
in this filing are the following financial statements:








Description
                  
                  PageReport
      of Independent Registered Public Accounting Firm
                  
                  F-2Consolidated
      Balance Sheets at December 31, 2008 and 2007
                  
                  F-3Consolidated
      Statements of Operations for the years ended December 31, 2008 and
      2007
                  
                  F-4Consolidated
      Statements of Stockholders’ Equity for the years ended December 31, 2008
      and 2007
                  
                  F-5Consolidated
      Statements of Cash Flows for the years ended December 31, 2008 and
      2007
                  
                  F-6Notes
      to the Financial Statements
                  
                  F-7

























F-1


REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM










To the
Board of Directors


Triple A
Medical, Inc.


Ovilla,
Texas





We have
audited the accompanying consolidated balance sheets of Triple A Medical, Inc. ,
as of December 31, 2008 and 2007, and the related consolidated statements of
operations, changes in stockholders' equity, and cash flows for the years then
ended. These consolidated financial statements are the responsibility of the
management of Triple A Medical, Inc.  Our responsibility is to express
an opinion on these consolidated financial statements based on our
audits.





We
conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform an audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. Triple A Medical, Inc is not
required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. Our audits included consideration of internal
control over financial reporting as a basis for designing audit procedures that
are appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of Triple A Medical, Inc’s internal control over
financial reporting. Accordingly, we express no such opinion. An audit also
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles
used and significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.





In our
opinion, the financial statements referred to above present fairly, in all
material respects, the financial position of Triple A Medical, Inc. as of
December 31, 2008 and 2007, and the results of its operations and its cash flows
for the periods described in conformity with accounting principles generally
accepted in the United States of America.





The
accompanying consolidated financial statements have been prepared assuming that
the Company will continue as a going concern. As discussed in Note 2 to the
financial statements, the Company has suffered recurring losses from operations
and has recurring deficits in cash flows from operating activities, which raises
substantial doubt about its ability to continue as a going concern. Management's
plans regarding these matters also are described in Note 2. The financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.







/s/  MALONE
& BAILEY, PC MALONE
& BAILEY, PC


www.malone-bailey.com


Houston,
Texas





April 15,
2009
































F-2


TRIPLE
      A MEDICAL, INC.Consolidated
      Balance SheetsDecember
      31, 2008 and 2007ASSETS
                                                        
                                                        2008
                                                        
                                                        
                                                        2007Current
      AssetsCash
      and cash equivalents
                                                        
                                                        $
                                                        47,954
                                                        
                                                        
                                                        $
                                                        270,906Accounts
      Receivable, net of allowance of $95,799 and $0
                                                          In
      2008 & 2007, respectively
                                                        
                                                        
                                                        22,083
                                                        
                                                        
                                                        
                                                        1,100Prepaid
      Expenses
                                                        
                                                        
                                                        -
                                                        
                                                        
                                                        
                                                        29,363Total
      Current Assets
                                                        
                                                        
                                                        70,037
                                                        
                                                        
                                                        
                                                        301,369Computer
      Equipment, net
                                                        
                                                        
                                                        15,057
                                                        
                                                        
                                                        
                                                        23,270Developed
      Software, net
                                                        
                                                        
                                                        286,035
                                                        
                                                        
                                                        
                                                        362,549TOTAL
      ASSETS
                                                        
                                                        $
                                                        371,129
                                                        
                                                        
                                                        $
                                                        687,188LIABILITIES
      AND STOCKHOLDERS' EQUITYCurrent
      LiabilitiesAccounts
      Payable and Accrued Expenses
                                                        
                                                        $
                                                        95,140
                                                        
                                                        
                                                        $
                                                        67,756Short-term
      Debt
                                                        
                                                        
                                                        40,398
                                                        
                                                        
                                                        
                                                        -Total
      Current Liabilities
                                                        
                                                        
                                                        135,538
                                                        
                                                        
                                                        
                                                        67,756Commitments
      and contingencies
                                                        
                                                        
                                                        -
                                                        
                                                        
                                                        
                                                        -Stockholders'
      EquityPreferred
      stock, $0.01 par value, 20,000,000 authorized,-0-  issued
      and outstanding
                                                        
                                                        
                                                        -
                                                        
                                                        
                                                        
                                                        -Common
      Stock, $.001 par value, 50,000,000 shares authorized,14,050,500
      and 13,744,000 shares issued and outstanding, respectively
                                                        
                                                        
                                                        14,051
                                                        
                                                        
                                                        
                                                        13,744Additional Paid-In Capital
                                                        
                                                        
                                                        1,655,697
                                                        
                                                        
                                                        
                                                        1,258,756Accumulated  Deficit
                                                        
                                                        
                                                        (1,434,157
                                                        )
                                                        
                                                        
                                                        (653,068
                                                        )Total Stockholders' Equity
                                                        
                                                        
                                                        235,591
                                                        
                                                        
                                                        
                                                        619,432TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
                                                        
                                                        $
                                                        371,129
                                                        
                                                        
                                                        $
                                                        687,188See
      accompanying summary of accounting policies and notes to consolidated
      financial statements.









F-3







TRIPLE
      A MEDICAL, INC.Consolidated
      Statements of OperationsYears
      Ended December 31, 2008 and 20072008
                    
                    
                    2007REVENUE
                    
                    $
                    542,165
                    
                    
                    $
                    207,443OPERATING
      EXPENSESDepreciation
      and amortization
                    
                    
                    84,727
                    
                    
                    
                    21,389Selling,
      General & Administrative:
                    
                    
                    1,213,978
                    
                    
                    
                    434,765Software
      Development Costs
                    
                    
                    26,500
                    
                    
                    
                    255,437TOTAL
      OPERATING EXPENSES
                    
                    
                    1,325,205
                    
                    
                    
                    711,591NET
      LOSS FROM OPERATIONS
                    
                    
                    (783,040
                    )
                    
                    
                    (504,148
                    )OTHER
      INCOME (EXPENSE)Interest
      income
                    
                    
                    2,349
                    
                    
                    
                    5,526Interest
      expense
                    
                    
                    (398
                    )
                    
                    
                    -TOTAL
      OTHER INCOME (EXPENSE)
                    
                    
                    1,951
                    
                    
                    
                    5,526NET
      LOSS
                    
                    $
                    (781,089
                    )
                    
                    $
                    (498,622
                    )Basic
      and diluted weighted average shares outstanding
                    
                    
                    14,007,255
                    
                    
                    
                    13,535,751Basic
      and diluted net loss per share
                    
                    $
                    (0.05
                    )
                    
                    $
                    (0.04
                    )See
      accompanying summary of accounting policies and notes to consolidated
      financial statements.


F-4


TRIPLE
      A MEDICAL, INC.
                          Consolidated
      Statements of Stockholders' Equity
                          Years
      Ended December 31, 2008 and 2007Common
      Stock
                        
                        
                        Paid-In
                        
                        
                        Subscription
                        
                        
                        AccumulatedShares
                        
                        
                        Amount
                        
                        
                        Capital
                        
                        
                        Receivable
                        
                        
                        Deficit
                        
                        
                        TotalsBalance
      at December 31, 2007
                        
                        
                        13,744,000
                        
                        
                        $
                        13,744
                        
                        
                        $
                        1,258,756
                        
                        
                        
                        
                        
                        $
                        (653,068
                        )
                        
                        $
                        619,432Contributed
      capital
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        244,000
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        244,000Imputed
      rent
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        2,000
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        2,000Cash
      received for stock
                        
                        
                        276,500
                        
                        
                        
                        277
                        
                        
                        
                        137,971
                        
                        
                        
                        (2,000
                        )
                        
                        
                        
                        
                        
                        
                        136,248Shares
      issued for services
                        
                        
                        30,000
                        
                        
                        
                        30
                        
                        
                        
                        14,970
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        15,000Net
      Loss
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        (781,089
                        )
                        
                        
                        (781089
                        )Balance
      at December 31, 2008
                        
                        
                        14,050,500
                        
                        
                        $
                        14,051
                        
                        
                        $
                        1,657,697
                        
                        
                        $
                        (2,000
                        )
                        
                        $
                        (1,434,157
                        )
                        
                        $
                        235,591See
      accompanying summary of accounting policies and notes to consolidated
      financial statements.


F-5


TRIPLE
      A MEDICAL, INC.Consolidated
      Statements of Cash FlowsYears
      Ended December 31, 2008 and 20072008
                  
                  
                  2007CASH
      FLOWS FROM OPERATING ACTIVITIESNet
      Loss
                  
                  $
                  (781,089
                  )
                  
                  $
                  (498,622
                  )Adjustments
      to reconcile net income to net cashprovided
      by operating activities:Depreciation
      and amortization
                  
                  
                  84,727
                  
                  
                  
                  21,389Common
      stock issued for services
                  
                  
                  15,000
                  
                  
                  
                  -Changes
      in operating assets and liabilities:Imputed
      rent
                  
                  
                  2,000
                  
                  
                  
                  8,000Accounts
      receivable
                  
                  
                  (22,084
                  )
                  
                  
                  -Accounts
      receivable - employee
                  
                  
                  1,100
                  
                  
                  
                  (1,100
                  )Prepaid
      expenses
                  
                  
                  29,363
                  
                  
                  
                  (29,363
                  )Accounts
      payable and accrued expenses
                  
                  
                  27,384
                  
                  
                  
                  34,760Net
      Cash Used in Operating Activities
                  
                  
                  (643,599
                  )
                  
                  
                  (464,936
                  )CASH
      FLOWS FROM INVESTING ACTIVITIESPurchase
      of fixed assets
                  
                  
                  -
                  
                  
                  
                  (27,886
                  )Net
      Cash Used in Investing Activities
                  
                  
                  -
                  
                  
                  
                  (27,886
                  )CASH
      FLOWS FROM FINANCING ACTIVITIESContributed
      capital
                  
                  
                  244,000
                  
                  
                  
                  376,000Proceeds
      from sale of stock
                  
                  
                  136,249
                  
                  
                  
                  122,000Payments
      on  short term debt
                  
                  
                  (5,000
                  )
                  
                  
                  -Proceeds
      from short term debt
                  
                  
                  45,398
                  
                  
                  
                  -Net
      Cash Provided by Financing Activities
                  
                  
                  420,647
                  
                  
                  
                  498,000NET
      INCREASE IN CASH AND CASH EQUIVALENTS (DECREASE)
                  
                  
                  (222,952
                  )
                  
                  
                  5,178CASH
      AND CASH EQUIVALENTS AT BEGINNING OF YEAR
                  
                  
                  270,906
                  
                  
                  
                  265,728CASH
      AND CASH EQUIVALENTS AT END OF YEAR
                  
                  $
                  47,954
                  
                  
                  $
                  270,906SUPPLEMENTAL
      DISCLOSURESInterest
      paid
                  
                  $
                  -
                  
                  
                  $
                  -Income taxes paid
                  
                  $
                  -
                  
                  
                  $
                  -See
      accompanying summary of accounting policies and notes to consolidated
      financial statements.





F-6


TRIPLE
A MEDICAL, INC.


Notes to
the Consolidated Financial Statements


December
31, 2008 and 2007








NOTE 1 –
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES





Nature of Activities,
History and Organization:





Triple A
Medical, Inc. (Triple A), through its wholly owned subsidiary Triple A Software,
Inc. (TAS), has developed and is in the process of selling and distributing a
proprietary software developed for use as an electronic medical record by
orthopedic surgeons. Triple A is located in Ovilla, Texas and was incorporated
on December 27, 2006 in Nevada.





Triple A
is the parent company of TAS, a Texas corporation. TAS was established in 2005
and since that time has been working to develop software. The software being
developed is designed as an easy to use, interactive software with customization
that can be made as it is used.





On
December 29, 2006, Triple A issued 13,500,000 shares of common stock in exchange
for a 100% equity interest in TAS. As a result of the share exchange, TAS became
the wholly owned subsidiary of Triple A. The share exchange was treated as a
recapitalization of TAS. The financial statements have been prepared as if TAS
had always been the reporting company and then on the share exchange date, had
changed its name and reorganized its capital stock.





The
financial statements also include the accounts of Triple A’s subsidiary, Phoenix
Ortho , LLC.





Significant Accounting
Policies





Use of
Estimates





The
preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect certain reported amounts and disclosures.  Accordingly, actual
results could differ from those estimates.





Cash and Cash
Equivalents





All
highly liquid investments with original maturities of three months or less are
stated at cost which approximates market value.





Property and
Equipment





Property
and equipment are carried at the cost of acquisition or construction and
depreciated over the estimated useful lives of the assets. Costs associated with
repair and maintenance are expensed as incurred. Costs associated with
improvements which extend the life, increase the capacity or improve the
efficiency of our property and equipment are capitalized and depreciated over
the remaining life of the related asset. Gains and losses on dispositions of
equipment are reflected in operations. Depreciation is provided using the
straight-line method over the estimated useful lives of the assets, which is 3
years.








F-7





Software Development
Costs





Triple A
follows Statement of Financial Accounting Standards 86, “Accounting for the
costs of computer software to Be Sold, Leased, or Otherwise
Marketed”.  In accordance with SFAS 86, internal costs incurred to
create computer software are charged to expense when incurred until
technological feasibility has been established for the product. Technological
feasibility is established upon completion of a detailed program design or, in
its absence, completion of a working model. After technological feasibility is
established, the costs of coding and testing and other costs of producing
product masters are capitalized. Cost capitalization ceases when the product is
available for general release to customers.





Capitalized
software costs are amortized on a product-by-product basis, starting when the
product is available for general release to customers. Annual amortization is
the greater of straight-line over the product's estimated useful life or the
percent of the product's current-year revenues as compared to the product's
anticipated future revenues.





Capitalized
software costs are evaluated for impairment on a product-by-product basis by a
comparison of the unamortized capitalized costs to the product's net realizable
value. The amount by which the unamortized capitalized costs exceed the net
realizable value is recognized as an impairment charge.





Revenue
Recognition





Triple A
recognizes revenue when persuasive evidence of an arrangement exists, delivery
has occurred or services have been rendered, the price is fixed or determinable,
and collectability is reasonably assured, under EITF 08-01. Triple A recognizes
revenue under multiple deliverable arrangements from installation and other
services as the services are performed.





Income
Taxes





Income
taxes are computed using the asset and liability method.  Under the asset
and liability method, deferred income tax assets and liabilities are determined
based on the differences between the financial reporting and tax bases of assets
and liabilities and are measured using the currently enacted tax rates and laws.
 A valuation allowance is provided for the amount of deferred tax assets
that, based on available evidence, are not expected to be realized.





Earnings (Loss) per
Share





Earnings
(loss) per share (basic) is calculated by dividing the net income (loss) by the
weighted average number of common shares outstanding for the period
covered.  As Triple A has no potentially dilutive securities, fully
diluted earnings (loss) per share is identical to earnings (loss) per share
(basic).





Fair Value of Financial
Instruments:





The
carrying amounts of cash, cash equivalents, accounts receivable, accounts
payable and notes payable approximate their fair values due to the short-term
maturities of these instruments.  The carrying amount of the Company’s
marketable securities and capital leases approximate fair value due to the
stated interest rates approximating market rates.









F-8





Recent Accounting
Pronouncements:





The
Company does not
expect  the  adoption  of  recently  issued  accounting
pronouncements  to have a significant  impact on the
Company’s  results of  operations, financial position or
cash flow.





NOTE 2 - GOING
CONCERN





Triple A
's financial statements have been presented on the basis that it is a going
concern, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business.  Triple A has suffered
recurring losses since inception and accumulated a deficit of $1,434,157 as of
December 31, 2008. Additionally, Triple A has incurred recurring deficits in
cash flows from operating activities.





Triple A 's ability to continue as a
going concern is dependent upon its ability to complete the development of its
developed software product with existing sources of capital, to successfully
market and implement its developed software product and to achieve profitable
operations.  The accompanying financial statements do not include any
adjustments that might result from the outcome of these
uncertainties.





NOTE 3 -
CONCENTRATIONS





Triple A
maintains demand deposit accounts which at times exceed FDIC insurance
limitations of $250,000 per account. Balances on deposit at financial
institutions as of December 31, 2007 in excess of FDIC deposit insurance amounts
were $20,906.





NOTE 4 - PROPERTY AND
EQUIPMENT





Property
and equipment consisted of the following at December 31, 2008 and
2007:





Description
              Life
              
              2008
      Amount
              
              
              2007AmountComputer
      equipment
              3
      years
              
              $
              24,639
              
              
              $
              24,639Accumulated
      depreciation
              
              
              
              (9,582
              )
              
              
              (1,369
              )$
              15,057
              
              
              $
              23,270





Depreciation
expense totaled $8,213 and $1,369 for the years ended December
31,  2008 and 2007, respectively.





NOTE 5 – CAPITALIZED
SOFTWARE DEVELOPMENT COSTS





Capitalized
software development costs at December 31, 2008 and 2007 consist of the
following:





2008
                        
                        
                        2007Software
                        
                        $
                        382,569
                        
                        
                        $
                        382,569Less:
      accumulated amortization
                        
                        
                        (96,534
                        )
                        
                        
                        (20,020
                        )$
                        286,035
                        
                        
                        $
                        362,549





F-9





Amortization
expense totaled $76,514 and $20,020 in 2008 and 2007, respectively





$255,437
of software development costs were expensed during 2007 and $26,500 in
2008.








NOTE 6 – SHORT-TERM NOTES
PAYABLE





Triple a
borrowed $45,398 in the form of a short term line of credit from Ortho Dev, LLC,
the entity responsible for developing its software in September 2008. This line
of credit matures in September 2009 and bears interest at a rate of 5.85%. the
balance on this line of credit amounted to $40,398 as of December 31,
2008





NOTE 7 – INCOME
TAXES





Deferred
tax assets at December 31, 2008 and 2007 consisted of the
following:





Year
      ended December 31, 2008
                          
                          
                          Year
      ended December 31, 2007Net
      operating loss carry forward
                          
                          $
                          481,493
                          
                          
                          $
                          222,043Less:
      valuation allowance
                          
                          
                          (483,493
                          )
                          
                          
                          (222,043
                          )Net
      deferred tax asset
                          
                          
                          -
                          
                          
                          
                          -





The net
deferred tax asset generated by the loss carry-forward has been fully reserved.
 The cumulative net operating loss carry-forward is approximately
$1,416,156 at December 31, 2008, and will expire in the years 2024 through
2028.





The
difference in the income tax benefit not shown in the consolidated statements of
operations and the amount at
that  would  result  if  the U.S.
Federal statutory
rate  of  34%  were  applied to pre-tax
loss for 2008 and 2007 is attributable to the valuation allowance.





The
realization of deferred tax benefits is contingent upon future
earnings.




NOTE 8 – RELATED PARTY
TRANSACTIONS





In order
to fund the development of the software, Triple A entered into  an
‘Investment and Net Revenue Agreement’ with Phoenix Ortho, LLC (ORTHO), an
entity controlled by a relative of the President of Triple A. In connection with
this agreement ORTHO provided Triple A $376,000 during 2007 and $244,000 in
2008. This cash is reflected as additional paid-in capital as of December 31,
2007 and 2008. In exchange for this contributed capital, Triple A provided ORTHO
with an income participation interest in its operations. The terms of this
agreement require Triple A to pay ORTHO 32.60% of the net income generated by
the business in the immediately preceding month. This Investment and net revenue
agreement has been assigned form Ortho to another entity controlled by the
owners, Phoenix Scap, LLP during 2006.








F-10





In
addition, office space has been contributed by related parties from April
2006  to March 2008 rent-free.  $2,000 in 2008 and $8,000 in
2007 has been imputed related to this office space.





NOTE 9 –
CONCENTRATIONS





Triple A
has a concentration of revenues based upon a limited number of customers. For
the year ended December 31, 2008 three customers comprised 76%  of
total revenues. For the year ended December 31, 2007 two customers comprised
93%  of total revenues.





Triple A
has contracted with the entity Ortho Dev, LLC to develop the software it uses to
provide its electronic medical records. All software development costs including
those capitalized as well as expense, as detailed in the following tables, have
been acquired from Ortho Dev, LLC.





Software
development costs paid to Ortho Dev and capitalized or expensed as of and for
the years ended December 31, 2008 & 2007, amounted to:








Software
      development costs
              
              2008
              
              
              2007Capitalized
              
              $
              382,569
              
              
              $
              382,569Expensed
              
              $
              26,500
              
              
              $
              255,437











F-11




ITEM
      9.
            CHANGES
      IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
      DISCLOSURE





We have
retained Malone & Bailey, PC as our registered independent public accounting
firm. We have


had no
disagreements with them on accounting and disclosure issues.








ITEM
9A.                   CONTROLS
AND PROCEDURES







Evaluation of Disclosure
Controls and Procedures




We
carried out an evaluation of the effectiveness of the design and operation of
our disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) as of December 31, 2008.  This
evaluation was accomplished under the supervision and with the participation of
our chief executive officer / principal executive officer, and chief financial
officer / principal financial officer who concluded that our disclosure controls
and procedures are not effective to ensure that all material information
required to be filed in the annual report on Form 10-K has been made known to
them.




Disclosure,
controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by in our reports
filed under the Securities Exchange Act of 1934, as amended (the "Act") is
accumulated and communicated to the issuer's management, including its principal
executive and principal financial officers, or persons performing similar
functions, as appropriate to allow timely decisions regarding required
disclosure.




Based
upon an evaluation conducted for the period ended December 31, 2008, our Chief
Executive and Chief Financial Officer as of December 31, 2008 and as of the date
of this Report, has concluded that as of the end of the periods covered by this
report, we have identified the following material weakness of our internal
controls:




·
            Reliance
      upon independent financial reporting consultants for review of critical
      accounting areas and disclosures and material non-standard
      transaction.




·
            Lack
      of sufficient accounting staff which results in a lack of segregation of
      duties necessary for a good system of internal
  control.




In order
to remedy our existing internal control deficiencies, as our finances allow, we
will hire additional accounting staff.




Management’s Annual Report
on Internal Control Over Financial Reporting




Our
management is responsible for establishing and maintaining adequate internal
control over financial reporting, as such term is defined in
Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control
system was designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes, in accordance with generally accepted accounting principles in the
United States of America.  Our internal control over financial
reporting includes those policies and procedures that (i) pertain to the
maintenance records that, in reasonable detail, accurately and fairly reflect
the transactions and dispositions of the assets of the Company; (ii) provide
reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with accounting principles
generally accepted in the United States of America, and that receipts and
expenditures of the Company are being made only in accordance with
authorizations of management of the Company; and (iii) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition,
use, or disposition of the Company’s assets that could have a material effect on
the financial statements.








6






Because
of inherent limitations, a system of internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become
inadequate due to change in conditions, or that the degree of compliance with
the policies or procedures may deteriorate.




Our
management conducted an evaluation of the effectiveness of our internal control
over financial reporting using the criteria set forth by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO) in Internal
Control—Integrated Framework at December 31, 2008.   Based on its
evaluation, our management concluded that, as of December 31, 2008, our internal
control over financial reporting was not effective because of limited staff and
a need for a full-time chief financial officer.  A material weakness
is a deficiency, or a combination of control deficiencies, in internal control
over financial reporting such that there is a reasonable possibility that a
material misstatement of the Company’s annual or interim financial statements
will not be prevented or detected on a timely basis.




This
annual report does not include an attestation report of the Company’s registered
public accounting firm regarding internal control over financial
reporting.  Management’s report was not subject to the attestation by the
Company’s registered public accounting firm pursuant to temporary rules of the
SEC that permit the Company to provide only management’s report in this annual
report.





Changes in Internal Controls
over Financial Reporting


We have
not yet made any changes in our internal controls over financial reporting that
occurred during the period covered by this report on Form 10-K that has
materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting.








ITEM
9B.                    OTHER
INFORMATION





None.


7


PART
III





ITEM
10.                   DIRECTORS, EXECUTIVE OFFICERS AND
CORPORATE GOVERNANCE





The
directors and officers of the company, their ages and principal positions are as
follows:





P.
      Morgan McCune
              30
              
              Director,
      President; Secretary and Director
                Since December
2006







Background
of Directors and Executive Officers:





P. Morgan
McCune.


AA Degree
Dallas Art Institute, Multimedia, Animation, Web Design, Web Developer, Graphic
Artist, Medical Illustrator 6 years experience, Co-developer NextGen Orthopedic
DB Developer NextGen Physical Therapy DB, Medical Illustrator for NextGen EMR,
Development Proficiency: SQL 2005, Visual Studio 2005, .NET, C#,
VB.





The
Registrant has one shareholder, the President, P. Morgan McCune, who owns at
least ten percent of the Company’s common stock. The initial Form 3 required to
be filed by the shareholder was filed late. P. Morgan McCune was not required to
file a Form 4 or Form 5 as his share holdings did not change.





ITEM
11.                    EXECUTIVE
COMPENSATION





Our sole
officer and director received the following compensation for the years of 2004
and 2005. He has no employment contract with the company.





Name
      of Person
                    Receiving
      compensation
                  
                  Capacity
      in which he served
                    to
      receive remuneration
                  
                  Aggregate
      remunerationP.
      Morgan McCune
                  
                  President,
      Secretary and Treasurer
                  
                  2008
      - $124,820
                    2007
      - $  72,000





We have
no employment agreements with any officer, director or employee.





ITEM
12.                   SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS





The following table lists the officers,
directors and stockholders who, at the date hereof, own of record or
beneficially, directly or indirectly, more than 10% of the outstanding common
stock, and all officers and directors of the company:





Title/relationshipto
      Issuer
                      
                      Name
      of Owner
                      
                      Amount
      Owned Before the Offering
                      
                      PercentPresident,
      Secretary and Director
                      
                      P.
      Morgan McCune
                      
                      13,000,000
                      
                      92.52%All
      officers andDirectors
      as a group
                      
                      
                      
                      13,000,000
                      
                      92.52%









8





No
options, warrants or rights have been issued by the Company.








ITEM
13.                   CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE





None.





As of the
date of this filing, there are no other agreements or proposed transactions,
whether direct or indirect, with anyone, but more particularly with any of the
following:


*           a
director or officer of the issuer;


*           any
principal security holder;


*           any
promoter of the issuer;


*
              any
      relative or spouse, or relative of such spouse, of the above referenced
      persons.







ITEM
14.                   PRINCIPAL
ACCOUNTING FEES AND SERVICES





(1) Audit
fees




The
aggregate fees billed for professional services rendered by our auditors, for
the audit of the registrant's annual financial statements and review of the
financial statements included in the registrant's Form 10-K or services that are
normally provided by the accountant in connection with statutory and regulatory
filings or engagements for fiscal years 2008 and 2007, were $23,500 and $15,163
respectively.




(2)
Audit-related fees




None




(3) Tax
fees




None




(4) All
other fees




None




(5) Audit
committee policies and procedures








9




The
Company does not have an audit committee.




(6) If
greater than 50 percent, disclose the percentage of hours expended on the
principal accountant's engagement to audit the registrant's financial statements
for the most recent fiscal year that were attributed to work performed by
persons other than the principal accountant's full-time, permanent
employees.




Not
applicable.




































10




PART
IV





ITEM
15.                   EXHIBITS,
FINANCIAL STATEMENT SCHEDULES





a)
1.           Financial Statements
Schedules





None





a)
3.           Exhibits





Exhibits





Exhibit
Number                                                      Name
of Exhibit





31.1           Certification
of Chief Executive Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as
enacted by Section 302 of the Sarbanes-Oxley Act of 2002.





31.2           Certification
of Chief Financial Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as
enacted by Section 302 of the Sarbanes-Oxley Act of 2002.





32.1           Certification
of Chief Executive Officer and Chief Financial Officer, pursuant to 18 United
States Code Section 1350, as enacted by Section 906 of the Sarbanes-Oxley Act of
2002.





























11





SIGNATURES





In
accordance with the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.





TRIPLE A
MEDICAL, INC.





By /s/ P. Morgan
McCune


P. Morgan
McCune, President, CFO





Date:
April 15, 2009





12